NCT01672684

Brief Summary

This randomized phase I trial studies at-home group video calling sessions in quality of life in rural patients with breast cancer. At-home group video calling support sessions may improve the well-being and quality of life of women who have breast cancer

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
34

participants targeted

Target at P25-P50 for phase_1 depression

Timeline
Completed

Started Oct 2012

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 20, 2012

Completed
7 days until next milestone

First Posted

Study publicly available on registry

August 27, 2012

Completed
1 month until next milestone

Study Start

First participant enrolled

October 1, 2012

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2013

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2014

Completed
Last Updated

October 17, 2014

Status Verified

October 1, 2014

Enrollment Period

1.2 years

First QC Date

August 20, 2012

Last Update Submit

October 15, 2014

Conditions

Keywords

quality of life

Outcome Measures

Primary Outcomes (2)

  • Feasibility of the study protocol as determined primarily through qualitative analysis of the group sessions and the interview data

    The major criterion for determining feasibility is to determine whether we can recruit rural women with breast cancer more rapidly using predominantly on-line procedures in this study than in our previous study that predominantly used face-to-face procedures. The qualitative data for determining the feasibility will be collected during the at-home group video calling sessions and from women's interviews conducted at the end of the study. Will be assessed using mixed methods.

    At 1 week post-intervention

  • Acceptability of the study protocol as determined primarily through qualitative analysis of the group sessions and the interview data

    The qualitative data for determining the acceptability will be collected during the at-home group video calling sessions and from women's interviews conducted at the end of the study. Will be assessed using mixed methods.

    At 1 week post-intervention

Secondary Outcomes (3)

  • Changes in quality of life (posttraumatic stress, depression symptoms, perceived stress, and positive states of mind)

    From baseline to 1 week post-intervention

  • Changes in satisfaction with social support

    From baseline to 1 week post-intervention

  • Changes in self-efficacy for coping with cancer

    From baseline to 1 week post-intervention

Study Arms (2)

Arm I (experimental arm)

EXPERIMENTAL

Participants complete at-home group video calling sessions for 1 1/2 hours once weekly for 8 weeks.

Procedure: support group therapy

Arm II (control arm)

ACTIVE COMPARATOR

Participants receive an educational workbook journal.

Other: educational intervention

Interventions

Complete at-home group video calling support sessions

Arm I (experimental arm)

Receive an educational workbook journal

Also known as: intervention, educational
Arm II (control arm)

Eligibility Criteria

Age21 Years+
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • To be eligible for this study, the participant must have been diagnosed with breast cancer within the previous 5 years prior to study entry; individuals who have been diagnosed with any stage of breast cancer are eligible
  • There are no limitations regarding allowable type and amount of prior therapy
  • There are no race/ethnic restrictions
  • There are no life expectancy restrictions
  • Neither Eastern Cooperative Oncology Group (ECOG) nor Karnofsky performance status will be employed
  • There are no requirements for organ and marrow function
  • Ability to understand and the willingness to sign a written informed consent document; this will be assessed in the telephone screen conducted by Lisa Frankel as she will review each section of the consent form with the participant and ask if she has any questions about it; this telephone screen will have been approved by the Stanford University Institutional Review Board (IRB), and Lisa Frankel will conduct the interviews in a private location to ensure confidentiality
  • Eligibility for this study requires that a woman be a resident of one of 27 rural counties in California (Alpine, Amador, Butte, Calaveras, Colusa, Del Norte, El Dorado, Glenn, Imperial, Inyo, Lake, Lassen, Madera, Mariposa, Modoc, Mono, Nevada, Placer, Plumas, Shasta, Sierra, Siskiyou, Sutter, Tehama, Trinity, Tuolumne, or Yuba, except we will not include women living within the following cities: Chico, Madera, Redding, Rocklin, Roseville or Yuba City, due to this study's more rural focus)
  • Eligibility for this study requires that a woman has sufficient hearing to be able to engage in conversation over the phone
  • Eligibility for this study requires that a woman has a private place available where she can access the internet
  • Eligibility for this study requires that a woman is potentially available to meet at the day of the week and time of the day that the group intervention is scheduled â in the event that she is randomly assigned to receive the at-home group calling intervention
  • Eligibility for this study requires that women have broadband or digital subscriber line (DSL) internet access
  • Eligibility for this study requires that women have a computer with a webcam and either a microphone or a phone available to call into the video conference

You may not qualify if:

  • There are no therapy restrictions
  • There are no restrictions regarding use of other investigational agents
  • Requirements regarding history of allergic reactions attributed to compounds of similar chemical or biologic composition to investigational agent or device are not applicable to this study
  • Pregnancy or nursing patients will not be excluded from the study
  • Patients who are cancer survivors or those who are human immunodeficiency virus (HIV)-positive will not be excluded from the study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Sierra Streams Institute

Nevada City, California, 95959, United States

Location

Stanford University Cancer Institute

Stanford, California, 94305, United States

Location

MeSH Terms

Conditions

DepressionStress Disorders, Post-TraumaticBreast Neoplasms

Interventions

Early Intervention, EducationalMethods

Condition Hierarchy (Ancestors)

Behavioral SymptomsBehaviorStress Disorders, TraumaticTrauma and Stressor Related DisordersMental DisordersNeoplasms by SiteNeoplasmsBreast DiseasesSkin DiseasesSkin and Connective Tissue Diseases

Intervention Hierarchy (Ancestors)

Child Health ServicesCommunity Health ServicesHealth ServicesHealth Care Facilities Workforce and ServicesPreventive Health ServicesInvestigative Techniques

Study Officials

  • Cheryl Koopman

    Stanford University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 1
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
INVESTIGATOR
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor (Research) of Psychiatry and Behavioral Sciences

Study Record Dates

First Submitted

August 20, 2012

First Posted

August 27, 2012

Study Start

October 1, 2012

Primary Completion

December 1, 2013

Study Completion

June 1, 2014

Last Updated

October 17, 2014

Record last verified: 2014-10

Locations